Literature DB >> 20579695

A comparative study of clinical value of single B-mode ultrasound guidance and B-mode combined with color doppler ultrasound guidance in mini-invasive percutaneous nephrolithotomy to decrease hemorrhagic complications.

Ming-Hua Lu1, Xiao-Yong Pu, Xin Gao, Xiang-Fu Zhou, Jian-Guang Qiu, Jie Si-Tu.   

Abstract

OBJECTIVES: To compare the clinical value of single B-mode ultrasonography and B-mode combined with color Doppler ultrasonography in the guidance of mini-invasive percutaneous nephrolithotomy (m-PCNL) to decrease the incidence of hemorrhagic complications.
METHODS: A total of 297 patients with renal stones who had undergone m-PCNL were retrospectively categorized into 2 groups. Group 1 (187 patients) underwent m-PCNL with single B-mode ultrasound guidance and group 2 (110 patients) underwent m-PCNL with combined B-mode and color Doppler ultrasound guidance. The clinical characteristics of the patients, intraoperative and postoperative characteristics, complications, especially hemorrhagic complications, and blood transfusion rate were recorded and compared.
RESULTS: No statistically significant differences in age, height, weight, stone burden, operative time, stone-free rate, or length of postoperative hospital stay were found between the 2 groups. In group 2, a statistically significant decrease in the transfusion rate was found compared with group 1 (P <.05). In group 1, 5 patients (2.6%) required a blood transfusion, 2 (1.1%) developed a renal arteriovenous fistula and required embolotherapy, 2 (1.1%) developed hemorrhage and required embolotherapy after surgery, 16 (8.6%) developed capillary hemorrhage during surgery but had no hemorrhage postoperatively. However, no serious hemorrhagic complications were found in group 2. Only 3 patients (2.7%) developed capillary hemorrhage during surgery, and no hemorrhage occurred postoperatively.
CONCLUSIONS: Using combined B-mode and color Doppler ultrasound guidance during in m-PCNL resulted in the real-time detection and avoidance of the renal blood vessels during puncture and decreased the incidence of hemorrhagic complications, especially in the patients with a solitary and compensative kidney.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20579695     DOI: 10.1016/j.urology.2009.08.091

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  Assessment of the SonixGPS system for its application in real-time ultrasonography navigation-guided percutaneous nephrolithotomy for the treatment of complex kidney stones.

Authors:  Xiang Li; Qingzhi Long; Xingfa Chen; Dalin He; Hui He
Journal:  Urolithiasis       Date:  2016-07-09       Impact factor: 3.436

2.  [Comparison of laparoscopic pyelolithotomy and percutaneous nephrolithotomy for renal pelvic stones larger than 2.5 cm].

Authors:  Xiao-Yong Pu; Jiu-Min Liu; Xue-Cheng Bi; Dong Li; Shang Huang; Yan-Hua Feng; Chu-Qi Lin
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

3.  Presence of a Novel Anatomical Structure May Cause Bleeding When Using the Calyx Access in Mini-Percutaneous Nephrolithotomy.

Authors:  Fangyou Lin; Bojun Li; Ting Rao; Yuan Ruan; Weimin Yu; Fan Cheng; Stéphane Larré
Journal:  Front Surg       Date:  2022-06-21

4.  Value of CT angiography in reducing the risk of hemorrhage associated with mini-percutaneous nephrolithotomy.

Authors:  Xiang-Jun Meng; Qi-Wu Mi; Tao Hu; Wei-De Zhong
Journal:  Int Braz J Urol       Date:  2015 Jul-Aug       Impact factor: 1.541

5.  Reducing postoperative morbidity of mini-invasive percutaneous nephrolithotomy: Would it help if blood vessels are left unharmed during puncture? A CONSORT-prospective randomized trial.

Authors:  Congcong Xu; Sheng Feng; Caixiu Lin; Yichun Zheng
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

6.  The ideal puncture approach for PCNL: Fluoroscopy, ultrasound or endoscopy?

Authors:  Bannakij Lojanapiwat
Journal:  Indian J Urol       Date:  2013-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.